Interpretation of very low avidity indices acquired with the Liaison XL Toxo IgG avidity assay in dating toxoplasmosis infection.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 10 09 2018
accepted: 02 11 2018
pubmed: 10 11 2018
medline: 6 5 2019
entrez: 10 11 2018
Statut: ppublish

Résumé

Congenital toxoplasmosis is an important cause of complications in pregnancy. Toxoplasmosis is often asymptomatic and thus serological tests are usually performed to screen for it. A first serum which exhibit both IgG and IgM may be due to nascent toxoplasmosis seroconversion, non-specific IgM reaction, or residual IgM. The IgG avidity test has been proposed to identify latent infections. A high index excludes recent toxoplasmosis whereas an intermediate or low index only suggests a recent infection, the caveats being that some people with latent Toxoplasma gondii infection show IgG with low or intermediate avidity. In this study, we investigated the ability of the Liaison XL Toxo IgG avidity (DiaSorin, Saluggia, Italy) assay to confirm recent infection when IgG avidity index is very low (≤ 0.1). Four thousand two hundred ninety-seven sera exhibiting both IgG and IgM were included and avidity was performed on the Liaison device according to the manufacturer's recommendations. One hundred twenty-six sera on the 297 sera which exhibited very low IgG avidity indices (≤ 0.1) could be exploited: 97% of sera with IgG avidity indices < 0.05 actually corresponded to recent infection (less than 3 months). A similar but less pronounced trend was observed for the sera exhibiting indices between 0.05 and 0.1 (69% corresponded to recent infections). The IgG avidity index data we obtained with the Liaison XL Toxo device are similar to those obtained with other devices. This body of consistent results underlines the interest of very low IgG avidity indices as a sign of probable recent toxoplasmosis.

Identifiants

pubmed: 30411219
doi: 10.1007/s10096-018-3421-5
pii: 10.1007/s10096-018-3421-5
doi:

Substances chimiques

Antibodies, Protozoan 0
Immunoglobulin G 0
Immunoglobulin M 0
Reagent Kits, Diagnostic 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

253-257

Références

Epidemiol Infect. 2004 Jun;132(3):541-8
pubmed: 15188723
J Clin Microbiol. 2005 Apr;43(4):1570-4
pubmed: 15814967
Diagn Microbiol Infect Dis. 2007 May;58(1):83-8
pubmed: 17368807
Ann Biol Clin (Paris). 2007 May-Jun;65(3):257-64
pubmed: 17502297
Diagn Microbiol Infect Dis. 2008 Nov;62(3):235-44
pubmed: 18715735
Ann Biol Clin (Paris). 2009 Mar-Apr;67(2):125-33
pubmed: 19297286
Diagn Microbiol Infect Dis. 2009 Jul;64(3):267-74
pubmed: 19395217
Clin Vaccine Immunol. 2011 Nov;18(11):1908-12
pubmed: 21880851
Clin Microbiol Rev. 2012 Apr;25(2):264-96
pubmed: 22491772
Clin Vaccine Immunol. 2012 Nov;19(11):1838-43
pubmed: 22993406
Clin Vaccine Immunol. 2013 Feb;20(2):197-204
pubmed: 23239801
Clin Infect Dis. 2013 May;56(9):1223-31
pubmed: 23362291
Eur J Clin Microbiol Infect Dis. 2017 May;36(5):847-852
pubmed: 27995345
PLoS Negl Trop Dis. 2017 Feb 16;11(2):e0005222
pubmed: 28207736
J Infect Dis. 1989 Apr;159(4):736-40
pubmed: 2926163
Am J Obstet Gynecol. 2018 Oct;219(4):386.e1-386.e9
pubmed: 29870736

Auteurs

Frédérique Boquel (F)

Service de Parasitologie-Mycologie, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière/Charles Foix, 75651, Paris Cedex 13, France.

Lorra Monpierre (L)

Service de Parasitologie-Mycologie, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière/Charles Foix, 75651, Paris Cedex 13, France.

Sébastien Imbert (S)

Service de Parasitologie-Mycologie, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière/Charles Foix, 75651, Paris Cedex 13, France.
Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, 75013, Paris, France.
AP-HP, Hôpital Pitié-Salpêtrière, Sorbonne Université, Paris, France.

Feriel Touafek (F)

Service de Parasitologie-Mycologie, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière/Charles Foix, 75651, Paris Cedex 13, France.

Régis Courtin (R)

Service de Parasitologie-Mycologie, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière/Charles Foix, 75651, Paris Cedex 13, France.

Renaud Piarroux (R)

Service de Parasitologie-Mycologie, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière/Charles Foix, 75651, Paris Cedex 13, France.
Institut Pierre-Louis d'Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpêtrière, Sorbonne Université, INSERM, Paris, France.

Luc Paris (L)

Service de Parasitologie-Mycologie, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière/Charles Foix, 75651, Paris Cedex 13, France. luc.paris@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH